StockData
iBio, Inc. logo

iBio, Inc. (IBIO) stock

IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$0.85+0.10 (+13.37%)

Close on Nov 18, 2026Market cap $54.54MP/E –Yield –

iBio total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

iBio's total debt was $643.00K at Dec 31, 2024. For fiscal 2024 it was $766.00K.

Annual total debt

PeriodPeriod endValueChange
FY2024Jun 30, 2024$766.00K–
FY2021Jun 30, 2021$0-100.0%
FY2020Jun 30, 2020$339.00K–
FY2019Jun 30, 2019$0–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2025CQ4 2024Dec 31, 2024$643.00K-97.1%
Q1 FY2025CQ3 2024Sep 30, 2024$706.00K–
Q4 FY2024CQ2 2024Jun 30, 2024$766.00K+2152.9%
Q3 FY2022CQ1 2022Mar 31, 2022$22.12M+16285.2%
Q2 FY2022CQ4 2021Dec 31, 2021$22.05M+9166.0%
Q4 FY2021CQ2 2021Jun 30, 2021$0-100.0%
Q3 FY2021CQ1 2021Mar 31, 2021$34.00K–
Q2 FY2021CQ4 2020Dec 31, 2020$135.00K–
Q1 FY2021CQ3 2020Sep 30, 2020$238.00K–
Q4 FY2020CQ2 2020Jun 30, 2020$339.00K–
Q4 FY2019CQ2 2019Jun 30, 2019$0–

More iBio figures

See a number that looks wrong?